GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » Cyclically Adjusted Price-to-FCF

Medistim ASA (OSTO:MEDIO) Cyclically Adjusted Price-to-FCF : 37.02 (As of May. 09, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Cyclically Adjusted Price-to-FCF?

As of today (2024-05-09), Medistim ASA's current share price is kr174.00. Medistim ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was kr4.70. Medistim ASA's Cyclically Adjusted Price-to-FCF for today is 37.02.

The historical rank and industry rank for Medistim ASA's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

OSTO:MEDIO' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 27.68   Med: 63.01   Max: 126.33
Current: 36.34

During the past years, Medistim ASA's highest Cyclically Adjusted Price-to-FCF was 126.33. The lowest was 27.68. And the median was 63.01.

OSTO:MEDIO's Cyclically Adjusted Price-to-FCF is ranked better than
55.51% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 44.08 vs OSTO:MEDIO: 36.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medistim ASA's adjusted free cash flow per share data for the three months ended in Mar. 2024 was kr1.208. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is kr4.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medistim ASA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Medistim ASA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Cyclically Adjusted Price-to-FCF Chart

Medistim ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.99 88.94 105.10 55.77 44.90

Medistim ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.85 62.91 46.72 44.90 38.30

Competitive Comparison of Medistim ASA's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Medistim ASA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Cyclically Adjusted Price-to-FCF falls into.



Medistim ASA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Medistim ASA's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=174.00/4.7
=37.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medistim ASA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.208/131.9000*131.9000
=1.208

Current CPI (Mar. 2024) = 131.9000.

Medistim ASA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.611 97.500 0.827
201409 0.619 98.500 0.829
201412 1.250 98.600 1.672
201503 0.335 99.200 0.445
201506 0.424 100.100 0.559
201509 0.580 100.600 0.760
201512 1.125 100.900 1.471
201603 -0.032 102.500 -0.041
201606 0.368 103.800 0.468
201609 0.463 104.200 0.586
201612 0.881 104.400 1.113
201703 0.745 105.000 0.936
201706 -0.105 105.800 -0.131
201709 0.729 105.900 0.908
201712 2.023 106.100 2.515
201803 0.351 107.300 0.431
201806 0.264 108.500 0.321
201809 1.053 109.500 1.268
201812 1.390 109.800 1.670
201903 0.598 110.400 0.714
201906 1.035 110.600 1.234
201909 1.266 111.100 1.503
201912 1.520 111.300 1.801
202003 1.238 111.200 1.468
202006 0.991 112.100 1.166
202009 0.761 112.900 0.889
202012 1.080 112.900 1.262
202103 0.992 114.600 1.142
202106 1.178 115.300 1.348
202109 2.278 117.500 2.557
202112 2.531 118.900 2.808
202203 1.230 119.800 1.354
202206 1.516 122.600 1.631
202209 1.675 125.600 1.759
202212 1.789 125.900 1.874
202303 0.035 127.600 0.036
202306 1.724 130.400 1.744
202309 2.292 129.800 2.329
202312 2.134 131.900 2.134
202403 1.208 131.900 1.208

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medistim ASA  (OSTO:MEDIO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Medistim ASA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA (OSTO:MEDIO) Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSTO:MEDIO) Headlines

No Headlines